These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6186415)

  • 1. Alpha-fetoprotein concentrations in maternal serum: relation to race and body weight.
    Crandall BF; Lebherz TB; Schroth PC; Matsumoto M
    Clin Chem; 1983 Mar; 29(3):531-3. PubMed ID: 6186415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester.
    Haddow JE; Kloza EM; Knight GJ; Smith DE
    Clin Chem; 1981 Jan; 27(1):133-4. PubMed ID: 6160923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical interpretation of maternal serum alpha-fetoprotein concentrations.
    Adams MJ; Windham GC; James LM; Greenberg F; Clayton-Hopkins JA; Reimer CB; Oakley GP
    Am J Obstet Gynecol; 1984 Feb; 148(3):241-54. PubMed ID: 6198913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
    Milunsky A; Jick SS; Bruell CL; MacLaughlin DS; Tsung YK; Jick H; Rothman KJ; Willett W
    Am J Obstet Gynecol; 1989 Aug; 161(2):291-7. PubMed ID: 2475017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Maternal Race and Weight Provides Equitable Performance in Serum Screening for Open Neural Tube Defects.
    Messerlian G; Strickland SW; Willbur J; Vaughan C; Koenig S; Wright T; Palomaki GE
    Clin Chem; 2024 Jul; 70(7):948-956. PubMed ID: 38965696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal alpha-fetoprotein screening: two years' experience in a low-risk district.
    Standing SJ; Brindle MJ; Macdonald AP; Lacey RW
    Br Med J (Clin Res Ed); 1981 Sep; 283(6293):705-7. PubMed ID: 6169386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High maternal serum alpha-fetoprotein and low birthweight. A study concerning possible correlation between maternal weight, smoking, and serum alpha-fetoprotein and subsequent birthweight and gestational age.
    Secher NJ; Eriksen PS; Hansen PK; Lenstrup C; Thisted J
    Am J Perinatol; 1985 Apr; 2(2):78-81. PubMed ID: 2420339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.
    Crandall BF; Robertson RD; Lebherz TB; King W; Schroth PC
    West J Med; 1983 Apr; 138(4):524-30. PubMed ID: 6191442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
    Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
    Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum alpha-fetoprotein screening in North Carolina: experience with more than twelve thousand pregnancies.
    Burton BK; Sowers SG; Nelson LH
    Am J Obstet Gynecol; 1983 Jun; 146(4):439-44. PubMed ID: 6190401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal testing for maternal serum alpha-fetoprotein.
    Schwager EJ; Weiss BD
    Am Fam Physician; 1987 Apr; 35(4):169-74. PubMed ID: 2436465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of infants with open spina bifida in relation to maternal serum alpha-fetoprotein level. Third report of the UK collaborative study on alpha-fetoprotein in relation to neural-tube defects.
    Br J Obstet Gynaecol; 1982 Jan; 89(1):3-7. PubMed ID: 6174142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum alpha-fetoprotein: II. Clinical evaluation of two automated immunoassays for maternal serum screening.
    Cate JC; Gadsden RH
    Ann Clin Lab Sci; 1991; 21(4):254-7. PubMed ID: 1713436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
    Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
    Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of maternal weight on maternal serum alpha-fetoprotein levels.
    Wald N; Cuckle H; Boreham J; Terzian E; Redman C
    Br J Obstet Gynaecol; 1981 Nov; 88(11):1094-6. PubMed ID: 6170309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum alpha-fetoprotein screening in a provincial Health District.
    Woolfson J; Holt EM; Whyman AE; Mabbs DV
    Br J Obstet Gynaecol; 1979 Feb; 86(2):87-90. PubMed ID: 85461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum alpha-fetoprotein screening, maternal weight, and detection efficiency.
    Macri JN; Kasturi RV; Krantz DA; Koch KE
    Am J Obstet Gynecol; 1986 Oct; 155(4):758-60. PubMed ID: 2429547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
    Sancken U; Bartels I
    Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum alpha-fetoprotein screening in Natal. Results of over 12 000 tests.
    Grace HJ; Hitzeroth HW; Op't Hof J
    S Afr Med J; 1984 Jan; 65(1):8-11. PubMed ID: 6198731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.